Astrazeneca
-
Gout Drug Lesinurad By AstraZeneca Receives Approval Recommendation From FDA Advisory Committee
-
FDA Gives AstraZeneca Brilinta Nod Of Approval For Longer-Term Use
-
AstraZeneca To Pay Inovio $727.5 Million For Experimental Cancer Drug
-
Metastatic Lung Cancer Treatment Gets FDA Nod Of Approval
-
AstraZeneca-Lilly Collaboration To Test New Combination Of Cancer Drugs
-
AstraZeneca Heart Drug Brilinta May Benefit Heart Patients But Carries Risks
-
FDA approves AstraZeneca's EPANOVA, adjunct to diet for people with very high triglyceride levels
Most Popular
